Click for best price
Postpemic Era Biosimilars/followonbiologics Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Biosimilars/follow-on-biologics Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Biosimilars/follow-on-biologics industry at home and abroad, estimate the overall market scale of the Biosimilars/follow-on-biologics industry and the market share of major countries, Biosimilars/follow-on-biologics industry, and study and judge the downstream market demand of Biosimilars/follow-on-biologics through systematic research, Analyze the competition pattern of Biosimilars/follow-on-biologics, so as to help solve the pain points of various stakeholders in Biosimilars/follow-on-biologics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Biosimilars/follow-on-biologics Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Biosimilars/follow-on-biologics Market?
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Major Type of Biosimilars/follow-on-biologics Covered in Research report:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Application Segments Covered in Research Market
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Biosimilars/follow-on-biologics Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Biosimilars/follow-on-biologics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Biosimilars/follow-on-biologics Market by Value
2.2.1 Global Biosimilars/follow-on-biologics Revenue by Type
2.2.2 Global Biosimilars/follow-on-biologics Market by Value (%)
2.3 Global Biosimilars/follow-on-biologics Market by Production
2.3.1 Global Biosimilars/follow-on-biologics Production by Type
2.3.2 Global Biosimilars/follow-on-biologics Market by Production (%)
3. The Major Driver of Biosimilars/follow-on-biologics Industry
3.1 Historical & Forecast Global Biosimilars/follow-on-biologics Demand
3.2 Largest Application for Biosimilars/follow-on-biologics (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Biosimilars/follow-on-biologics Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Biosimilars/follow-on-biologics Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Biosimilars/follow-on-biologics Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Biosimilars/follow-on-biologics Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Biosimilars/follow-on-biologics Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Biosimilars/follow-on-biologics Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Biosimilars/follow-on-biologics Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Biosimilars/follow-on-biologics Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Biosimilars/follow-on-biologics Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Biosimilars/follow-on-biologics Average Price Trend
12.1 Market Price for Each Type of Biosimilars/follow-on-biologics in US (2018-2022)
12.2 Market Price for Each Type of Biosimilars/follow-on-biologics in Europe (2018-2022)
12.3 Market Price for Each Type of Biosimilars/follow-on-biologics in China (2018-2022)
12.4 Market Price for Each Type of Biosimilars/follow-on-biologics in Japan (2018-2022)
12.5 Market Price for Each Type of Biosimilars/follow-on-biologics in India (2018-2022)
12.6 Market Price for Each Type of Biosimilars/follow-on-biologics in Korea (2018-2022)
12.7 Market Price for Each Type of Biosimilars/follow-on-biologics in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Biosimilars/follow-on-biologics Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Biosimilars/follow-on-biologics
14. Biosimilars/follow-on-biologics Competitive Landscape
14.1 Novartis (Sandoz)
14.1.1 Novartis (Sandoz) Company Profiles
14.1.2 Novartis (Sandoz) Product Introduction
14.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Synthon Pharmaceuticals
14.2.1 Synthon Pharmaceuticals Company Profiles
14.2.2 Synthon Pharmaceuticals Product Introduction
14.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Teva Pharmaceutical Industries
14.3.1 Teva Pharmaceutical Industries Company Profiles
14.3.2 Teva Pharmaceutical Industries Product Introduction
14.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 LG Life Sciences
14.4.1 LG Life Sciences Company Profiles
14.4.2 LG Life Sciences Product Introduction
14.4.3 LG Life Sciences Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Celltrion Biocon
14.5.1 Celltrion Biocon Company Profiles
14.5.2 Celltrion Biocon Product Introduction
14.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Hospira
14.6.1 Hospira Company Profiles
14.6.2 Hospira Product Introduction
14.6.3 Hospira Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Merck Serono (Merck)
14.7.1 Merck Serono (Merck) Company Profiles
14.7.2 Merck Serono (Merck) Product Introduction
14.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Biogen idec
14.8.1 Biogen idec Company Profiles
14.8.2 Biogen idec Product Introduction
14.8.3 Biogen idec Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Genentech (Roche)
14.9.1 Genentech (Roche) Company Profiles
14.9.2 Genentech (Roche) Product Introduction
14.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Demand by Application of Biosimilars/follow-on-biologics Industry (Volume)
Figure 2. Biosimilars/follow-on-biologics Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2022
Figure 5. US Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Biosimilars/follow-on-biologics Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Biosimilars/follow-on-biologics Revenue, by Type (Million USD) (2018-2028)
Table 4. Biosimilars/follow-on-biologics Production, by Type (K Unit) (2018-2028)
Table 5. Biosimilars/follow-on-biologics Demand (K Unit) by Application (2018-2028)
Table 6. Biosimilars/follow-on-biologics Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Biosimilars/follow-on-biologics Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Biosimilars/follow-on-biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Biosimilars/follow-on-biologics in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Novartis (Sandoz) Profiles
Table 61. Novartis (Sandoz) Biosimilars/follow-on-biologics Product Introduction
Table 62. Novartis (Sandoz) Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Novartis (Sandoz) Strategic initiatives
Table 64. Synthon Pharmaceuticals Profiles
Table 65. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product Introduction
Table 66. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Synthon Pharmaceuticals Strategic initiatives
Table 68. Teva Pharmaceutical Industries Profiles
Table 69. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product Introduction
Table 70. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Teva Pharmaceutical Industries Strategic initiatives
Table 72. LG Life Sciences Profiles
Table 73. LG Life Sciences Biosimilars/follow-on-biologics Product Introduction
Table 74. LG Life Sciences Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. LG Life Sciences Strategic initiatives
Table 76. Celltrion Biocon Profiles
Table 77. Celltrion Biocon Biosimilars/follow-on-biologics Product Introduction
Table 78. Celltrion Biocon Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Celltrion Biocon Strategic initiatives
Table 80. Hospira Profiles
Table 81. Hospira Biosimilars/follow-on-biologics Product Introduction
Table 82. Hospira Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Hospira Strategic initiatives
Table 84. Merck Serono (Merck) Profiles
Table 85. Merck Serono (Merck) Biosimilars/follow-on-biologics Product Introduction
Table 86. Merck Serono (Merck) Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Merck Serono (Merck) Strategic initiatives
Table 88. Biogen idec Profiles
Table 89. Biogen idec Biosimilars/follow-on-biologics Product Introduction
Table 90. Biogen idec Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Biogen idec Strategic initiatives
Table 92. Genentech (Roche) Profiles
Table 93. Genentech (Roche) Biosimilars/follow-on-biologics Product Introduction
Table 94. Genentech (Roche) Biosimilars/follow-on-biologics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Genentech (Roche) Strategic initiatives
